Mount Sinai Comprehensive Cancer Center

Summary

Mount Sinai Comprehensive Cancer Center is a medical facility located in Miami Beach, Florida. This center is recognized for care of Cancer, Melanoma, Lung Cancer, Pancreatic Cancer, Breast Cancer and other specialties. Mount Sinai Comprehensive Cancer Center is involved with conducting 86 clinical trials across 116 conditions. There are 5 research doctors associated with this hospital, such as Mike Cusnir, MD, Michael A. Schwartz, Brian Slomovitz, and Oleg Gligich.

Top PIs

Clinical Trials running at Mount Sinai Comprehensive Cancer Center

Endometrial Cancer

Chronic Lymphocytic Leukemia

Lymphoma

Cancer

Cervical Cancer

Lung Cancer

Ovarian Cancer

Mantle Cell Lymphoma

Follicular Lymphoma

Breast Cancer

Sacituzumab Tirumotecan + Pembrolizumab

for Endometrial Cancer

Researchers are looking for new ways to treat people with proficient mismatch repair (pMMR) endometrial cancer (EC) that is advanced or recurrent. * EC is a type of cancer that starts in the tissues inside the uterus (womb) * pMMR indicates that certain normal proteins are present in the cancer cells * Advanced means the cancer has spread locally or to other parts of the body (metastatic) and cannot be removed with surgery * Recurrent means the cancer came back after surgery Sacituzumab tirumotecan (also known as sac-TMT) and pembrolizumab are the study medicines. Sac-TMT is an antibody drug conjugate (ADC). An ADC attaches to specific targets on cancer cells and delivers treatment to destroy those cells. The goal of this study is to learn if people who receive sac-TMT with pembrolizumab live longer and without the cancer getting worse compared to people who receive pembrolizumab alone.

Recruiting

2 awards

Phase 3

2 criteria

ACR-368

for Ovarian Cancer

This trial tests a new drug, ACR-368, alone or with a small dose of another drug, gemcitabine, in patients whose cancers don't respond to standard treatments. A special test helps decide which treatment might work best for each patient. Gemcitabine has been used with other drugs for various cancers, including pancreatic, lung, ovarian, and breast cancers.

Recruiting

1 award

Phase 2

10 criteria

Sapanisertib + Serabelisib + Paclitaxel

for Endometrial Cancer

This is a Phase 2, multicenter, open-label, single-arm study to evaluate the efficacy and safety of sapanisertib and serabelisib (PIKTOR) with paclitaxel in participants with advanced or recurrent endometrial cancer.

Recruiting

1 award

Phase 2

6 criteria